FGFR/EGFR dual inhibitor (Suzhou Kintor Pharmaceuticals)

N/A

Report date: 2026/05/09 20:00:18
NME

Base Information

Drug NameFGFR/EGFR dual inhibitor (Suzhou Kintor Pharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEpidermal growth factor receptor erbB1 inhibitorsFibroblast growth factor receptors inhibitors
TargetsEpidermal growth factor receptor erbB1Fibroblast growth factor receptors
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSuzhou Koshine Biomedica Inc
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Koshine Biomedica Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A